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THE HARVEY LECTURES, SERIES 75

CELLULAR ORIGIN OF TRANSFORMING GENES OF
RNA TUMOR VIRUSES*
HIDESABURO HANAFUSA
The Rockefeller University, New York, New York

I

N the past decade, RNA tumor virus research has attracted a
great deal of attention, as a model system of viral carcino
genesis and perhaps in part because of the discovery of reverse
transcriptase in virions which catalyzes the synthesis of DNA
using RNA as a template (Temin and Mizutani, 1970; Baltimore,
1970). Recently there seems to be another surge of interest in
the RNA tumor viruses. One reason for the renewed interest is
the long awaited identification of the viral gene product which
is directly responsible for cell transformation (Brugge and
Erikson, 1977; Purchio et al., 1977). Another factor is the dis
closure of the unique mechanism with which virus is able to
integrate into host cell DNA and regulate the expression of the
integrated provirus. These two aspects will be parts of the dis
cussion presented, which will focus on the possible general pro
cess in the evolution of the oncogenic viruses and its implication
to the understanding of the process of cell transformation.
I. RNA TUMOR VIRUS AS A TRANSFORMING AGENT
The RNA tumor virus systems have developed into a large
family of viruses since isolation of viruses early this century by
Ellermann and Bang (1909), Rous (1911), and Fujinami and In
amoto (1914). The viruses are classified into three major groups:
sarcoma, acute leukemia, and lymphoid leukosis viruses, on the
basis of their pathogenicity in infected animals (Hanafusa, 1977).
Typical RNA tumor viruses of avian species are listed in Table
I. In addition to Rous sarcoma virus (RSV), two independent
*Lecture delivered March 20, 1980.
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TABLE I
AVIAN RNA TUMOR VIRUSES
Sarcoma virus

Virus strains

Target cells

Latent
period (in
vivo)
Virus
replication

Rous sarcoma virus
(RSV)
Bryan strain
(BH-RSV)
Schmidt-Ruppin
strain (SRRSV)
Prague strain
(PR-RSV)·
Bratislava strain 77
(B77)
Fujinami sarcoma
virus (FSV)
Fibroblasts

5-10 days
+ or -

Acute leukemia
virus

Lymphoid
leukosis virus

Avian
myeloblastosis
virus (AMY)
Avian
erythroblastosis
virus (AEV)
Avian
myelocytomatosis virus
(MCV)

Avian
lymphomatosis
virus RPLl2
Rous associated
viruses (RAVs)
Resistance
inducing factor
(RIF)

Bone marrow
cells
(fibroblasts)
(epithelial cells)
1-3 weeks

Bursa of
Fabricius
4-6 months
+

isolates, Fujinami sarcoma virus (FSV) and Bratislava 77 (Thurzo
et al., 1963), are known as sarcoma viruses, and recently more
additions have been reported (Carr and Campbell, 1958; Itohara
et al.,· 1978). There are a number of "strains" of RSV which
are called by the name of researchers or by the name of the
place where the original Rous virus was passaged and acquired
some altered properties (Hanafusa, 1977). Acute leukemia vi
ruses and lymphoid leukosis viruses, the second and third groups
(Table I), are distinguishable on a number of accounts. First,
acute leukemia viruses, as indicated by the name, cause an acute
type of leukemia in animals compared to lymphoid leukosis_ vi
ruses, which need a long latent period of several months. The
primary target tissues are different: the bone marrow for acute
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leukemia virus and the bursa of Fabricius for leukosis viruses.
Perhaps more importantly, all of the acute leukemia viruses are
defective in virus replication because of the substitution of their
genomes by inserts of unique sequences, presumably derived
from host cells. Therefore, as will be further discussed later, our
current understanding is that acute leukemia viruses, and also
sarcoma viruses, are able to transform host cells because they
incorporate their unique transforming sequences into the cells.
On the other hand, lymphoid leukosis viruses do not appear
to have such specific cellular sequences within their genome. It
is considered, therefore, that leukosis viruses cause tumors in
lymphoid cells because of replication of the virus for a long
period of time, thereby altering the expression of some host cell
genes. The mechanism of tumor formation by leukosis viruses
is one of the issues actively being pursued by many groups and
will not be discussed here. It should be stressed, however, that
leukosis viruses are not defective in replication and serve as
helper viruses for both defective sarcoma virus and defective
acute leukemia viruses.
Cell transformation by avian sarcoma virus is a rapid and
quantitative process (Hanafusa, 1969). Upon infection with one
or more infectious virus, cells change dramatically in their ap
pearance: cells which we call morphologically transformed be
come more refractile and assume either a round or spindle shape
due to the changes in cell surface. These morphological changes
are generally associated with changes in a number of other cel
lular phenotypes, including the capacity of continuous growth
under conditions where normal cells cannot grow (Hanafusa,
1977).
These changes can take place within 24-30 hours following
introduction of a single virus into the cell. After infection, viral
genome RNA is copied into DNA by reverse transcriptase which
is associated with viral RNA within the viral particles. Double
stranded viral DNA thus formed will be integrated into cellular.
DNA, and thereafter transmitted to daughter cells by cell division
(Varmus et al., 1975; Gaianni et al., 1975; Weinberg, 1977). Re
cently it was discovered that in the process of the synthesis of
viral DNA using viqll RNA templates, the nucleotide sequences
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present at the termini of viral RNA are duplicated and added to
both ends of linear DNA in a form of direct repeats (Shank et
al., 1978; Hsu et al., 1978). Furthermore, these long terminal
repeats (LTR) are preserved in the integrated proviral DNA, and
they are flanked by cellular sequences, suggesting that the LTR
is directly involved in the process of integration of viral DNA
(Hughes et al., 1978; Sabran et al., 1979; Hager et al., 1979;
Vande Woude et al., 1979). As the nucleotide sequences of the
LTR of various retrovirus have been analyzed, it has become
apparent that these terminal sequences contain a set of sequences
similar to those found in other eukaryotic DNAs which may
serve as a promoter of RNA transcription (Yamamoto et al.,
1980; Sutcliffe et al., 1980; Blair ei al., 1980). This means that
the proviral DNA transcription is not controlled by a cellular
promoter but. rather by its own promoter signal introduced into
the cell chromosome together with the coding sequences of the
viral genome.
The primary transcript of RSV provirus appears to be the 39
S RNA which is the same size as the genomic RNA found in
virions. This RNA contains four defined genes: gag for viral
structural proteins, pol for the reverse transcriptase and env for
envelope glycoproteins, and src for the transforming protein.
The first three genes are essential for making complete virus and
are shared by both lymphoid leukosis virus and nondefective
strains of RSV. The src gene codes for a 60,000-dalton protein
which is considered to be responsible for cell transformation and
sarcoma formation (Brugge and Erikson, 1977; Purchio et al.,
1977). The four genes described above are mapped on the non
defective RSV genome in the order 5'-gag-pol-env-src-c-poly(A)3' (Wang, 1978). The sequences known as "c" are commonly
present in most avian retroviruses, and a portion of it forms a
part of the LTR which includes the promoter sequences. The
corresponding genetic structure of lymphoid leukosis virus ge
nome is shown by 5 '-gag-pol-env-c-poly(A)-3'.
II.

GENERATION OF NEW SARCOMA VIRUSES

Historically, the comparison of RNAs of these two types of
viruses led to the recognition of the presence of the src gene.
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When nondefective RSV is passaged in tissue cultures, usually
a mutant is segregated, which retains replicating capacity but
not transforming capacity (Vogt, 1971; Kawai and Hanafusa,
1972; Martin and Duesberg, 1972). The mutants are called trans. formation defective or td mutants. The RNA of td mutants is
smaller than that of RSV and characteristically lacks a specific
portion of the RNA sequences near the 3' end (Duesberg and
Vogt, 1973; Wang et al., 1975, 1976; Joho et al., 1975; Lai et
al., 1973). Therefore, the genetic structure of these td mutants
is essentially the same as that of lymphoid leukosis viruses.
Because the deletion of this set of RNA sequences always cor
relates with the lack of cell-transforming capacity of the virus,
· this region is considered to be responsible for cell transformation
and thus defined as the src gene (Wang et al., 1976; Stehelin
et al., 1976a; Hayward, 1977; Hanafusa, 1977; Vogt, 1977; Wang,
1978). The extent of the deletion was originally thought to be
uniform for various td mutants (Wang et al., 1975).
In 1975, Sadaaki Kawai working in our laboratory at the time,
obtained several isolates of this class of spontaneous deletion
mutants of Schmidt-Ruppin strain of RSV (SR-RSV). Defined
as transformation defective, these mutants do not cause any cell
transformation in infected cultures. However, we obtained evi
dence suggesting that, instead of the complete deletion of the
src gene, some of the mutants still retain a small portion of the
src gene (Kawai et al., 1977). Previously we isolated a mutant
of RSV which is temperature sensitive (ts) in its capacity to
transform cells, but not to replicate (Kawai and Hanafusa, 1971).
Therefore, the mutation must be in the src gene. When cells are
doubly infected with this ts mutant, tsNY68, and one of the td
mutant isolate�, the products of some combinations were less
temperature sensitive, indicating the formation of recombinants
which had lost the ts lesion. The results were interpreted as
indicating that these td mutants contained a small portion of src
which corresponded to the temperature-sensitive lesion of the.
ts mutant. Indeed, the size of the RNA of these td mutants was
shown to be slightly larger than that of other standard leukosis
viruses (Kawai et al., 1977).
The first indication that the src gene originated from cellular
DNA sequences came from a hybridization study by Stehelin
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et al., (1976a,b). These investigators prepared DNA comple
mentary to the src gene of RSV using reverse transcriptase. This
cDNAs,c can hybridize with RNA of RSV but not with RNA of
lymphoid leukosis viruses or td mutants. However, DNA of
normal chicken cells showed a substantial degree of hybridization
with this cDNAs,c• Furthermore, the sequences homologous to
the src gene were detectable in DNA of normal cells of many
avian species (Stehelin et al., 1976b) and also later in mammalian
and fish DNAs when less stringent conditions were used for
molecular hybridization (Spector et al., 1978a). This src-related
DNA in normal cells is transcribed into RNA (Wang et al., 1977;
Spector et al., 1978b), which sediments at approximately 26 S
in a sucrose gradient. The amounts of src-related RNA in normal
cells were independent of the level of expression of leukosis
virus-related sequences present in DNA of chicken cells. Fur
thermore, the 26 S src-related RNA is apparently not linked to
the endogenous viral sequences, and src-related sequences and
endogenous viral sequences were shown to reside at different
sites on the cell chromosomes (Wang et al., 1977; Padgett et al.,
1977; Spector et al., 1978b).
The amounts of such RNA species in various types of cells
are shown in Table II. In normal uninfected chicken cells which
happen to be the type expressing very little viral RNA, the
amount of RNA transcripts of gag or env genes is extremely low
TABLE II

CONTENT OF GENE-SPECIFIC RNAs 1N VIRUS-INFECTED CELLS"
RNA content (copies/cell)
Region
analyzed
gag
pol
env
src
C

Uninfected cells

RAV-2-infected cells

0.2
NDb
0.5

9,800
9,400
16,000

ND

17,000

5

" From Hayward (1977).
b Not determined.

7

SR-RSV-infected
cells
10,000
10,200
20,000
18,000
19,500
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(Hayward and Hanafusa, 1973). In cells infected with the lym
phoid leukosis virus, RAV-2, the amount of RNA transcripts of
these genes is high because of the active synthesis of viral RNA.
However, the level of about 5-10 copies of src-related sequences
present in uninfected cells remains unchanged in the RAV-2
infected cells, indicating that exogenous virus infection does not
alter the extent of expression of endogenous src-related se
quences (Hayward, 1977; Wang et al., 1977). Cells infected with
RSV obviously contain large amounts of RNA transcripts of all
four genes, because all of them are present in the sarcoma virus
genome.
The existence of sequences related to the src gene of RSV in
DNA of normal chickens and other vertebrate cells suggests the
idea that virus might have picked up these sequences and thus
become oncogenic. However, in the past, attempts to obtain
sarcoma virus from chickens infected with lymphoid leukosis
viruses have failed. On the other hand, there are some obser
vations which imply the process of the generation of murine
sarcoma viruses (MSV). In contrast to the isolation of sarcoma
viruses from spontaneous tumors in chickens, many strains of
MSV now widely used were made in the laboratory. When mu
rine leukemia virus was maintained by repeated passages in mice
(Moloney, 1966), or rats (Harvey, 1964; Kirsten and Mayer,
1967), sarcomas were formed in these animals. Viruses isolated
from the resulting tumors were defective in replication; these
isolates were called murine sarcoma viruses because they in
duced foci on mouse cells and produced sarcoma in mice. In
teresting observations were made when cDNAs homologous to
the sarcoma virus and nonhomologous to helper leukemia se
quences were employed to examine their homology with cellular
and viral nucleic acids (Scolnick et al., I 973, 1975; Scolnick and
Parks, 1974; Roy-Burman and Klement, 1975; Anderson and
Robbins, 1976; Frankel and Fischinger, 1976, 1977). First, se
quences specific to Kirsten sarcoma virus and Moloney sarcoma
virus were not the same. Second, cDNA to Kirsten sarcoma
virus-specific sequences hybridized well with rat cell DNA, but
not with mouse cell DNA. Conversely, cDNA to Moloney sar
coma virus sequences hybridized with DNA of mouse cells but
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not with that of rat cells. Therefore, it appeared that each sar
coma virus was generated via recombination with respective host
cell sequences.
Because we found that some td mutants of RSV retained a
small portion of the src gene, we considered that these sequences
might serve for homologous recombination with the cellular src
related sequences, and thus increase the probability of generating
sarcoma virus. Table III shows some data of early experiments.
Td mutants were inoculated into the wing-web of newborn
chicks. Newborn chicks were used because they were known
to support growth of virus without immediate immunological
response, and also because animals should provide a larger num
ber of cells compared with in vitro tissue cultures; thus, this
would increase the chance of recombination between viral and
cellular genomes.
By definition, td mutants do not cause cell transformation r
and indeed did not produce tumors at the site of injection. Then,
beginning at about 2 months, we noticed the appearance of tu
mors, generally one, but sometimes in multiple numbers, at vari
ous sites distal from the original injection site: back, breast, leg,
and various internal organs. From every tumor we were able to
recover viruses fully capable of inducing sarcomagenic trans
formation both in vitro and in vivo. In order to rule out the
FORMATION OF

Soun

Experiment

TABLE III
TUMORS BY

td

MUTANTS OF

Virus

2
td
td
td
td

Control
td IOI
td 105
td 107
td 108
RAV-I
td 106
td 107
IOI Repurified
107A Repurified
108 Repurified
109 Repurified

SR-RSV

Number of chickens with
solid tumors/total
0/5
2/5
1/5
2/4
3/4
0/8
0/7
2/7
4/16
0/15
9/16
4/8
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possibility that the tumor formation was due to the presence of
a minute amount of sarcoma virus as a contaminant in the td
mutant stocks, the td mutants were carefully purified by terminal
dilution passages. Injection with these viruses confirmed that the
generation of sarcoma virus is reproducible as shown in Table
III (exp. 2) (Hanafusa et al., 1977).
It should be pointed out here that some td mutants were unable
to produce tumors. Mutants which have complete deletions of
the src gene, such as td106 and 107A, cannot recombine with
the cellular sequences. The long latency for the formation of
tumors in general suggests a low frequency of the genetic inter
action even in the positive cases.
The viruses isolated from tumors were designated ''recovered
avian sarcoma virus" (rASV) followed by the number of the
chicken from which each virus was isolated. Foci of transformed
cells induced by the recovered viruses were similar to each other,
despite the varying origin of tissues where tumors were formed.
They were rather distinct, however, from foci induced by stan
dard Schmidt-Ruppin RSV from which the td mutants were
derived. These results suggested that we had obtained a new
type of sarcoma virus. The isolation of similar rASVs was ob
served by Vigne et al. (1979).
The scheme for the generation of rASV is essentially as shown
in Fig. 1. In most cases the size of RNA of the recovered viruses
was similar to that of Schmidt-Ruppin RSV. This was attributed
to the restoration of the src gene, because RNA of rASV hy
bridized with more than 90% of cDNAs,c, whereas RNA of td
mutants used for generation of rASVs contained only 10 to 30%
of src-specific sequences (Halpern et al., 1979). Therefore, one
can conclude that from 70 to 90% of the src gene of recovered
ASV is derived from the host cell sequences.
The relationship of the src-specific sequences between re
covered virus and standard RSV was studied by L.-H. Wang
and others (Wang et al., 1978) by comparing RNase T 1 -resistant
oligonucleotide fingerprints. The fingerprint patterns were sur
prisingly similar to each other, but RNA of several isolates of
rASV consistently contained a new set of oligonucleotides. Fur
thermore, we were able to obtain similar recovered viruses from
quails infected with the same td mutants used for chickens. The
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c

FIG. I. The generation of rASV. The genetic structures of SR-RSV, its td
mutant and rASV are schematically shown, based on data obtained from the size
of RNAs, hybridization with cDNAs,c and T 1 oligonucleotide fingerprints.

comparison of fingerprints of chicken-derived rASVs and quail
derived rASVs showed a few distinct differences between these
two types of virus RNA, while RNAs of rASVs recovered from
the same species of animals were identical to each other (Wang
et al., 1979) (Fig. 2). These experiments demonstrated that the
sequences regained in recovered ASV src gene were indeed de
rived from cellular sequences present in each species of animals
which were closely related but not identical.
III.

TRANSFORMATION AS A RESULT OF THE EXPRESSION OF
NORMAL CELLULAR ENZYME

The product of the src gene of RSV was first identified by
Erikson and his associates (Brugge and Erikson, 1977; Purchio
et al., 1977). They injected Schmidt-Ruppin RSV into newborn
rabbits and produced tumors. Sera of rabbits carrying regressing
RSV tumors were shown to have a capacity to precipitate a
protein of molecular weight of about 60,000 from extracts of
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FIG. 2. Fingerprint patterns of RNase T,-resistanl oligonucleotides of viral 32 P-labeled RNAs. 32 P-labled viral 60 to 70 S RNAs
were digested with RNase T,, and digestion products were separated by electrophoresis and homochromatography. (A) SR-RSV;
(B) rASV-C 145 obtained from a chicken tumor; and (C) rASV-Q 3042-13 obtained from a quail tumor. Spots indicated by arrows
are src-specific oligonucleotides: open arrows are those present in SR-RSV RNA and solid arrows are those not present in RNA
of SR-RSV but present in rASV RNAs.
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RSV-transformed cells, but not of uninfected or lymphoid leu
kosis virus-infected cells. Further studies showed that this pro
tein is a phosphoprotein which has a protein kinase activity
(Collett and Erikson, 1978; Levinson et al., 1978).
When we applied this technique to extracts of cells transformed
by rASVs, 60K proteins (p60) were precipitable by the antisera
as expected, and the proteins were associated with a protein
kinase activity (Karess et al., 1979). The protein kinase activity
was detected by the transfer of phosphate from ')'-ATP to an
aceptor protein molecule. In this case, antigen-antibody complex
precipitated by the aid of staphylococcal protein A was mixed
with [')'-32P]ATP. The most closely associated protein molecule,
immunoglobulin became labeled with 32P. Therefore, as shown
in Fig. 3, the heavy chain of IgG of about 52,000 daltons was
strongly phosphorylated. In addition, in this particular experi
ment phosphates were also transferred to p60 itself. Later studies
by Hunter and Sefton (1980) showed that this protein kinase
associated with the src protein is unique in phosphorylating ty
rosine residues of substrate proteins rather than serine or thre
onine residues, sites of phosphorylation by known cellular pro
tein kinases. Because phosphorylation of proteins is known to
be associated with various regulatory processes in cells, the in
creased level of phosphorylating activity by the src protein may
well serve as the trigger for the process of cell transformation;
the analysis of this process is the current topic of research in
many laboratories.
Figure 3 also shows that extracts of nontransformed cells,
either normal chicken cells or td virus-infected cells contain
limited amounts of p60 precipitable by the same immune serum,
and this protein showed the same protein kinase activity (Collett
et al., 1978, 1979; Oppermann et al., 1979; Karess et al., 1979).
An src-related protein in normal chicken cells can be found also
in normal cells of many mammalian species (Oppermann et al.,
1979; Collett et al., 1979). The phosphorylation is specific to
tyrosine residues, and the proteins are structurally very similar
to the 60K pr:otein made in transformed cells (Hunter and Sefton,
1980). As discussed before, normal cells are known to contain
src-related nucleotides in both DNA and RNA. Therefore, it

A

B
a

5 2-

b

C

-

a

d

b

C

d

e

f

52-

F1G. 3. Autoradiogram of products of protein kinase reaction after electrophoresis in 8.5% polyacrylamide gel. (A) Trans
formed and(B) nontransformed cells. (A) Kinase activity by immunoprecipitates of(a) SR-RSV-infected cells with nonimmune
serum; (b) SR-RSV-infected cells with immune serum; (c) rASV-C 1441-infected cells with immune serum; (d) rASV-C 157infected cells with immune serum. (B) Kinase activity immunoprecipitated from uninfected cells (a, b, c) or tdl08-infected
cells (d, e, f): (a, d) immune serum; (b, e) immune serum preabsorbed with virion proteins; (c, f) nonimmune serum.
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This process itself is essentially similar to the transduction in
bacteriophage, although the process of recombination involved
in the transduction may not be similar. The cellular protein kinase
gene is now linked to the viral genome, which has a strong
promoter that allows efficient transcription of the entire viral
genome, irrespective of the site of integration, which results in
the production of a high level of the kinase.
However, one still cannot dismiss another possibility: that a
portion of the src gene retained by the td mutants could have
a crucial role. In the retained portion, the sequences of viral src
and its cellular counterpart could be different; only p60 made
by viral sequences could be effective for cell transformation.
If the first scheme is correct, this means that the mere
overproduction of a certain protein (such as protein kinase) could
be the cause of cell transformation. At the moment, there is no
clear indication whether viral and cellular products are func
tionally different, and therefore we cannot make a definitive
conclusion in the chicken system. However, with Moloney mu
rine sarcoma virus, molecular cloning of the viral transforming
sequences and its cellular counterpart was performed (Vande
Woude et al., 1979). When cellular counterpart DNA was trans
fected into normal cells, no cell transformation took place. But
when the cellular counterpart DNA was ligated to the terminal
repeats of the virus, the DNA efficiently induced cell transfor
mation upon transfection (Oskarsson et al., 1980). These results
support the idea described in the first scheme.
IV.

EXISTENCE OF MANY TRANSFORMING GENES

It has become more apparent by now that there are many
different transforming genes. The src gene of RSV is only one
of them. Recently T. Hanafusa and others in our laboratory
studied the genetic structure of Fujinami sarcoma virus as part
of a comparative analysis of transforming genes of various strains
of avian sarcoma virus (Wang et al., 1980; Hanafusa et al., 1980;
Lee et al., 1980). This Fujinami sarcoma virus (FSV) was isolated
in Japan at almost the same time as RSV was isolated, and is
as potent as RSV in sarcomagenic action in chickens (Fujinami
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and Inamoto, 1914). To our surprise, the genome of FSV does
not contain the src sequences of RSV. The virus is very defective
in replication, and the viral RNA is only 28 S or about 5000
nucleotides. The FSV RNA contains viral sequences at both the
5' and 3' termini, but the middle of the genome is substituted
by a set of unique sequences. The viral RNA does not hybridize
to cDNAs,c and contains no oligonucleotide specific to src. A
large protein of molecular weight about 140,000 can be found in
FSV-transformed cells by immunoprecipitation with antisera
against the gag gene product (structural protein) of lymphoid
leukosis viruses. This protein of 140,000 daltons (p l40) seems
to be the only viral product found in FSV-transformed non-virus
producing cells and thus is likely to be a transforming protein.
The p140 of FSV also appears to be associated with a protein
kinase activity which phosphorylates specifically tyrosine resi
dues of substrate proteins (Feldman et al., 1980). Two other
avian sarcoma viruses recently characterized, PRCII and Y73,
appear to be similar to FSV rather than RSV, in their overall
genetic structures (Vogt et al., 1980; Kawai et al., 1980).
The genetic structures of some representative RNA tumor
viruses are shown in Fig. 4, which illustrates the diversity of the
genetic structure of the transforming retroviruses. The portions
shown by the open bar are the inserts of unique sequences into
the genomes of lymphoid leukosis virus. The viral sequences are
probably essential in providing the large terminal repeats which
ensure the integration and efficient transcription, and perhaps
5'-terminal sequences required for packaging of viral RNA into
virions. In many cases, the unique sequences have been shown
to have homologous counterparts in DNA of normal vertebrate
cells. In general, the inserts of all of these viruses are not com
mon to each other, suggesting that many different sets of cellular
sequences can act as transforming genes. Recent studies with
FSV showed that the unique sequence of FSV is homologous
to the genome of feline sarcoma virus (Shibuya et al., 1980).
This means that the sarcomagenic sequences of a chicken virus
and a feline virus have a common origin; probably the cognate
genes in normal chicken and feline cell DNA were picked up
independently by avian and feline retroviruses. Perhaps it is also
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FIG. 4. The genetic structures of some representative retroviruses. The regions
of the genomes shown by the open bars are the inserts unique to each virus.
Data are obtained from Wang et al. (1975), Bister et al. (1979), Hanafusa et al.
(1980), Shih et al. (1978), Donoghue et al. (1979), and Shields et al. (1979).

worth mentioning that the gene products of some acute leukemia
viruses such as avian erythroblastosis virus appear to be spe
cifically involved in the differentiation process of blood cells
(Graf and Beug, 1978; Graf et al., 1980).
It seems likely, therefore, that the sequences we call trans
forming genes are the genes of cellular enzymes possibly involved
in various regulatory processes. Linking these genes with virus
genomes could be considered as natural cloning of cellular genes,
with retrovirus serving as cloning vehicles. Such a recombination
may also occur with other cellular genes, but unless some overt
changes such as cell transformation are induced·, such recom
binants would not be recognized and selected for.
The comparison shown in Fig. 4 illustrates that the structure
of RSV is unique among these transforming viruses because it
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is the only virus in which its transforming gene is located outside
of the replicative region of prototype leukosis virus. As a con
sequence, RSV is the only known transforming virus which is
not defective in virus replication. When we demonstrated the
defectiveness of Bryan strain of RSV for the first time (Hanafusa
et al., 1963), Rubin pointed out the possibility that the defec
tiveness of the replicative function of the virus is correlated with
its transforming capacity, considering the model of defective
transducing phages (Rubin, 1964). This concept was quickly dis
missed when we found that other RSV strains are nondefective
(Hanafusa, 1964). In _retrospect, Rubin's concept may be basi
cally right. As seen in a few examples shown in Fig. 4, nearly
all transforming retroviruses are defective because of the sub
stitution of a significant part of the viral genome by cellular
sequences. It is intriguing that nondefective RSV was an excep
tional existence, since this class of RSV has been· most invaluable
for the genetic analysis of the transforming virus, and for the
analysis of the transformation process in infected cells.
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